Angiocentric Pattern - CISMeF

" /> Angiocentric Pattern - CISMeF

CISMeF

chu

Angiocentric PatternNCIt concept

Preferred Label : Angiocentric Pattern;

Details

Origin ID

C35905;

UMLS CUI

C1332291;

Peut être observé dans la(les) pathologie(s)
- Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
- Recurrent Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
- Refractory Primary Cutaneous CD8-Positive Aggressive Epidermotropic Cytotoxic T-Cell Lymphoma [NCIt concept]
Semantic type(s)
- Finding [UMLS semantic type]
is_finding_of_disease
- Adult Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Angiocentric Glioma [NCIt concept]
- Angiocentric Immunoproliferative Lesion [NCIt concept]
- Central Nervous System Lymphomatoid Granulomatosis [NCIt concept]
- Childhood Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Childhood Lymphomatoid Granulomatosis [NCIt concept]
- Cutaneous Lymphomatoid Granulomatosis [NCIt concept]
- Grade I Lymphomatoid Granulomatosis [NCIt concept]
- Grade II Lymphomatoid Granulomatosis [NCIt concept]
- Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Lymphomatoid Granulomatosis [NCIt concept]
- Pulmonary Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Adult Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Childhood Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Childhood Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Grade I Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Grade II Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Grade III Lymphomatoid Granulomatosis [NCIt concept]
- Recurrent Lymphomatoid Granulomatosis [NCIt concept]
- Refractory Lymphomatoid Granulomatosis [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients

Nous contacter.
03/07/2025

© Rouen University Hospital. Any partial or total use of this material must mention the source.